AIM: It is well known that highly trained athletes suffer from a high incidence of upper respiratory tract infections (URTI). Secretory immunoglobulin A (SIgA) is a major effector of mucosal surface protection against microorganisms causing URTI. Although several studies have investigated the relationship between falls in SIgA levels and appearance of URTI symptoms, the relationship is not yet clear. METHODS: We prospectively investigated the relationship between daily changes in SIgA and appearance of URTI symptoms in collegiate soccer players during a training period of 2 months. RESULTS: Five of 12 subjects exhibited URTI symptoms during the study period. The SIgA level did not significantly decrease before appearance of URTI symptoms. However, the saliva flow rate and SIgA secretion rate tended to decrease 3 days before the appearance of URTI symptoms compared to that in the non-infection period (31.3+/-19, -42.2+/-20.6%, respectively). CONCLUSIONS: We could not demonstrate a significant relationship between decreased SIgA levels and appearance of URTI symptoms during the training period. However, our findings suggest that monitoring of SIgA secretion rate may be useful for assessment of risk status of athletes for URTI.
AIM: It is well known that highly trained athletes suffer from a high incidence of upper respiratory tract infections (URTI). Secretory immunoglobulin A (SIgA) is a major effector of mucosal surface protection against microorganisms causing URTI. Although several studies have investigated the relationship between falls in SIgA levels and appearance of URTI symptoms, the relationship is not yet clear. METHODS: We prospectively investigated the relationship between daily changes in SIgA and appearance of URTI symptoms in collegiate soccer players during a training period of 2 months. RESULTS: Five of 12 subjects exhibited URTI symptoms during the study period. The SIgA level did not significantly decrease before appearance of URTI symptoms. However, the saliva flow rate and SIgA secretion rate tended to decrease 3 days before the appearance of URTI symptoms compared to that in the non-infection period (31.3+/-19, -42.2+/-20.6%, respectively). CONCLUSIONS: We could not demonstrate a significant relationship between decreased SIgA levels and appearance of URTI symptoms during the training period. However, our findings suggest that monitoring of SIgA secretion rate may be useful for assessment of risk status of athletes for URTI.
Authors: C G Engeland; F N Hugo; J B Hilgert; G G Nascimento; R Junges; H-J Lim; P T Marucha; J A Bosch Journal: Brain Behav Immun Date: 2015-08-28 Impact factor: 7.217
Authors: Mohammad S Ahmad; Ahmed Bhayat; Muhammad Sohail Zafar; Khalid H Al-Samadani Journal: Int J Environ Res Public Health Date: 2017-04-20 Impact factor: 3.390
Authors: Despoina Tzira; Anargyroula Prezerakou; Ioannis Papadatos; Artemis Vintila; Anastasia Bartzeliotou; Filia Apostolakou; Ioannis Papassotiriou; Vassiliki Papaevangelou Journal: SAGE Open Med Date: 2018-09-25
Authors: Rômulo Vasconcelos Teixeira; Gilmário Ricarte Batista; Arnaldo Luis Mortatti; Paulo Moreira Silva Dantas; Breno Guilherme de Araújo Tinôco Cabral Journal: Int J Environ Res Public Health Date: 2020-08-20 Impact factor: 3.390
Authors: Ryland Morgans; Patrick Orme; Eduard Bezuglov; Rocco Di Michele; Alexandre Moreira Journal: Int J Environ Res Public Health Date: 2022-09-18 Impact factor: 4.614